Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Interventions to help support caregivers of people with a brain or spinal cord tumour.

Boele FW, Rooney AG, Bulbeck H, Sherwood P.

Cochrane Database Syst Rev. 2019 Jul 2;7:CD012582. doi: 10.1002/14651858.CD012582.pub2.

PMID:
31264707
2.

Defining unmet clinical need across the pathway of brain tumor care: a patient and carer perspective.

Sage W, Fernández-Méndez R, Crofton A, Gifford MJ, Bannykh A, Chrysaphinis C, Tingley E, Bulbeck H, Brahmbhatt M, Pickard JD, Walter FM, Brodbelt A, Price SJ, Joannides AJ.

Cancer Manag Res. 2019 Mar 19;11:2189-2202. doi: 10.2147/CMAR.S175886. eCollection 2019.

3.

Clinical Development of Novel Drug-Radiotherapy Combinations.

Ahmad SS, Crittenden MR, Tran PT, Kluetz PG, Blumenthal GM, Bulbeck H, Baird RD, Williams KJ, Illidge T, Hahn SM, Lawrence TS, Spears PA, Walker AJ, Sharma RA.

Clin Cancer Res. 2019 Mar 1;25(5):1455-1461. doi: 10.1158/1078-0432.CCR-18-2466. Epub 2018 Nov 29.

PMID:
30498095
4.

Letter to the Editor. Phase III randomized controlled trials are essential to properly evaluate the role of radiotherapy in WHO grade II meningioma.

Jenkinson MD, Weber DC, Haylock BJ, Sherratt FC, Young B, Weller M, Bulbeck H, Culeddu G, Hughes DA, Brain A, Das K, Preusser M, Francis P, Gamble C.

J Neurosurg. 2018 Oct;129(4):1104-1105. doi: 10.3171/2018.6.JNS181418. Epub 2018 Aug 17. No abstract available.

5.

Brain tumor research in the United Kingdom: current perspective and future challenges. A strategy document from the NCRI Brain Tumor CSG.

Kurian KM, Jenkinson MD, Brennan PM, Grant R, Jefferies S, Rooney AG, Bulbeck H, Erridge SC, Mills S, McBain C, McCabe MG, Price SJ, Marino S, Moyes E, Qian W, Waldman A, Vaqas B, Keatley D, Burchill P, Watts C.

Neurooncol Pract. 2018 Mar;5(1):10-17. doi: 10.1093/nop/npx022. Epub 2017 Aug 30. Review.

6.

Intraoperative imaging technology to maximise extent of resection for glioma.

Jenkinson MD, Barone DG, Bryant A, Vale L, Bulbeck H, Lawrie TA, Hart MG, Watts C.

Cochrane Database Syst Rev. 2018 Jan 22;1:CD012788. doi: 10.1002/14651858.CD012788.pub2. Review.

7.

Postprogression survival in patients with glioblastoma treated with concurrent chemoradiotherapy: a routine care cohort study.

Majewska P, Ioannidis S, Raza MH, Tanna N, Bulbeck H, Williams M.

CNS Oncol. 2017 Oct;6(4):307-313. doi: 10.2217/cns-2017-0001. Epub 2017 Oct 9.

8.

Priorities for methodological research on patient and public involvement in clinical trials: A modified Delphi process.

Kearney A, Williamson P, Young B, Bagley H, Gamble C, Denegri S, Muir D, Simon NA, Thomas S, Elliot JT, Bulbeck H, Crocker JC, Planner C, Vale C, Clarke M, Sprosen T, Woolfall K.

Health Expect. 2017 Dec;20(6):1401-1410. doi: 10.1111/hex.12583. Epub 2017 Jun 15.

9.

European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma.

Pace A, Dirven L, Koekkoek JAF, Golla H, Fleming J, Rudà R, Marosi C, Le Rhun E, Grant R, Oliver K, Oberg I, Bulbeck HJ, Rooney AG, Henriksson R, Pasman HRW, Oberndorfer S, Weller M, Taphoorn MJB; European Association of Neuro-Oncology palliative care task force.

Lancet Oncol. 2017 Jun;18(6):e330-e340. doi: 10.1016/S1470-2045(17)30345-5. Review.

10.

Clinical development of new drug-radiotherapy combinations.

Sharma RA, Plummer R, Stock JK, Greenhalgh TA, Ataman O, Kelly S, Clay R, Adams RA, Baird RD, Billingham L, Brown SR, Buckland S, Bulbeck H, Chalmers AJ, Clack G, Cranston AN, Damstrup L, Ferraldeschi R, Forster MD, Golec J, Hagan RM, Hall E, Hanauske AR, Harrington KJ, Haswell T, Hawkins MA, Illidge T, Jones H, Kennedy AS, McDonald F, Melcher T, O'Connor JP, Pollard JR, Saunders MP, Sebag-Montefiore D, Smitt M, Staffurth J, Stratford IJ, Wedge SR; NCRI CTRad Academia-Pharma Joint Working Group.

Nat Rev Clin Oncol. 2016 Oct;13(10):627-42. doi: 10.1038/nrclinonc.2016.79. Epub 2016 Jun 1.

11.

Interventions for the management of fatigue in adults with a primary brain tumour.

Day J, Yust-Katz S, Cachia D, Wefel J, Katz LH, Tremont I, Bulbeck H, Armstrong T, Rooney AG.

Cochrane Database Syst Rev. 2016 Apr 13;4:CD011376. doi: 10.1002/14651858.CD011376.pub2. Review.

PMID:
27074263
12.

Neurocognitive Deficits and Neurocognitive Rehabilitation in Adult Brain Tumors.

Day J, Gillespie DC, Rooney AG, Bulbeck HJ, Zienius K, Boele F, Grant R.

Curr Treat Options Neurol. 2016 May;18(5):22. doi: 10.1007/s11940-016-0406-5. Review.

PMID:
27044316
13.

The ROAM/EORTC-1308 trial: Radiation versus Observation following surgical resection of Atypical Meningioma: study protocol for a randomised controlled trial.

Jenkinson MD, Javadpour M, Haylock BJ, Young B, Gillard H, Vinten J, Bulbeck H, Das K, Farrell M, Looby S, Hickey H, Preusser M, Mallucci CL, Hughes D, Gamble C, Weber DC.

Trials. 2015 Nov 14;16:519. doi: 10.1186/s13063-015-1040-3.

14.

The Importance of Quality Patient Advocacy to Biobanks: A Lay Perspective from Independent Cancer Patients Voice (ICPV), Based in the United Kingdom.

Wilcox M, Grayson M, MacKenzie M, Stobart H, Bulbeck H, Flavel R.

Adv Exp Med Biol. 2015;864:171-83. doi: 10.1007/978-3-319-20579-3_14.

PMID:
26420622

Supplemental Content

Loading ...
Support Center